Strong Free Cash FlowConsistent and growing free cash flow provides durable financial flexibility: it funds R&D, capex and share repurchases, supports debt reduction and cushions cyclical downturns. The $102M operating cash in 2025 and positive FCF track record enable reinvestment without raising leverage.
Diversified End MarketsShifting mix toward medical, industrial and aerospace reduces single-market concentration risk and raises revenue quality. These end markets offer higher engineering content, longer program life cycles and stronger bookings, improving predictability and margin sustainability versus cyclic transportation exposure.
Margin ExpansionSustained gross- and EBITDA-margin improvement reflects favorable mix and operational leverage. Higher margins enhance cash generation and create a buffer against volume downturns, enabling continued investment in product development and selective M&A to reinforce long-term profitability.